Acadia Healthcare (NASDAQ:ACHC) Stock Rating Lowered by Bank of America

Acadia Healthcare (NASDAQ:ACHC) was downgraded by Bank of America from a “buy” rating to a “neutral” rating in a research report issued to clients and investors on Wednesday, MarketBeat reports. They presently have a $25.00 target price on the stock, down from their previous target price of $27.00. Bank of America‘s target price would indicate a potential upside of 12.06% from the stock’s previous close.

Several other equities analysts also recently weighed in on ACHC. Royal Bank Of Canada dropped their target price on shares of Acadia Healthcare from $43.00 to $28.00 and set an “outperform” rating for the company in a report on Wednesday, August 13th. KeyCorp dropped their target price on shares of Acadia Healthcare from $65.00 to $55.00 and set an “overweight” rating for the company in a report on Wednesday, May 14th. Guggenheim dropped their target price on shares of Acadia Healthcare from $36.00 to $29.00 and set a “buy” rating for the company in a report on Thursday, August 7th. Wall Street Zen raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Sunday, August 3rd. Finally, Stephens raised shares of Acadia Healthcare to a “hold” rating in a research note on Monday, June 2nd. Eight analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $39.00.

Acadia Healthcare Stock Performance

Shares of ACHC opened at $22.31 on Wednesday. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.73. The company has a 50-day simple moving average of $22.13 and a 200-day simple moving average of $24.43. Acadia Healthcare has a 52-week low of $17.13 and a 52-week high of $79.82. The company has a market capitalization of $2.06 billion, a PE ratio of 14.77, a P/E/G ratio of 4.14 and a beta of 0.89.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The firm had revenue of $869.23 million during the quarter, compared to the consensus estimate of $839.59 million. During the same period last year, the firm posted $0.91 EPS. The firm’s revenue for the quarter was up 9.2% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. Equities research analysts predict that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Acadia Healthcare

Hedge funds have recently modified their holdings of the company. Verdence Capital Advisors LLC boosted its position in shares of Acadia Healthcare by 3.3% in the second quarter. Verdence Capital Advisors LLC now owns 14,656 shares of the company’s stock worth $333,000 after acquiring an additional 465 shares during the last quarter. EverSource Wealth Advisors LLC boosted its position in shares of Acadia Healthcare by 54.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after acquiring an additional 497 shares during the last quarter. PNC Financial Services Group Inc. boosted its position in shares of Acadia Healthcare by 10.3% in the first quarter. PNC Financial Services Group Inc. now owns 6,672 shares of the company’s stock worth $202,000 after acquiring an additional 622 shares during the last quarter. LPL Financial LLC boosted its position in shares of Acadia Healthcare by 1.2% in the first quarter. LPL Financial LLC now owns 56,527 shares of the company’s stock worth $1,651,000 after acquiring an additional 697 shares during the last quarter. Finally, Quantinno Capital Management LP boosted its position in shares of Acadia Healthcare by 9.0% in the fourth quarter. Quantinno Capital Management LP now owns 8,695 shares of the company’s stock worth $345,000 after acquiring an additional 721 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.